141263-01-6

Basic information

• Product Name: Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-thio-b-D-glucopyranoside
• Synonyms: Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-thio-b-D-glucopyranoside;Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-thio-beta-D-glucopyranoside;Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-b-D-thioglucopyranoside;b-D-Glucopyranoside, ethyl 2,3-bis-O-(phenylMethyl)-4,6-O-(phenylMethylene)-1-thio-;Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-thio-β-D-glucopyranoside
• CAS NO: 141263-01-6
• Molecular Formula: C₂₉H₃₂O₅S
• Molecular Weight: 492.62638
• Mol File: 141263-01-6.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 623.3±55.0 °C(Predicted)
• Appearance: /
• Density: 1.23±0.1 g/cm3(Predicted)
• CAS DataBase Reference: Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-thio-b-D-glucopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-thio-b-D-glucopyranoside(141263-01-6)
• EPA Substance Registry System: Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-thio-b-D-glucopyranoside(141263-01-6)

Safety Data

• Hazardous Substances Data: 141263-01-6(Hazardous Substances Data)

Usage

General Description

Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-thio-b-D-glucopyranoside is a chemical compound that is used in organic synthesis and has potential applications in pharmaceuticals. It is a derivative of glucose, with multiple benzyl groups attached to its structure. Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-thio-b-D-glucopyranoside has been studied for its potential bioactivity, including its anti-inflammatory and antioxidant properties. Its unique structure and potential medicinal uses make it an interesting compound for further research and development.

Upstream product

• 32934-24-0 ethyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside 
• 604-69-3 β-D-glucose pentaacetate 
• 7473-36-1 ethyl 1-thio-β-D-glucopyranoside 
• 1125-88-8 benzaldehyde dimethyl acetal 
• 20701-61-5 ethyl 4,6-O-benzylidene-1-thio-β-D-glucopyranoside 
• 100-39-0 benzyl bromide 

Downstream Products

• 155520-85-7 C₇₆H₇₉NO₁₇ 
• 155544-28-8 C₇₄H₇₇NO₁₆ 
• 155520-81-3 Acetic acid (2R,3R,4S,5R,6S)-4,5-bis-benzyloxy-6-ethylsulfanyl-2-phenylcarbamoyloxymethyl-tetrahydro-pyran-3-yl ester 
• 152964-70-0 ethyl 2,3-di-O-benzyl-1-thio-β-D-glucopyranoside 
• 141263-02-7 ethyl 2,3,6-tri-O-benzyl-1-thio-β-D-glucopyranoside 
• 141263-09-4 Benzyl 2,4-di-O-benzyl-3-O-<2,3,6-tri-O-benzyl-4-O-(2,4,6-tri-O-acetyl-3-O-allyl-β-D-galactopyranosyl)-α-D-glucopyranosyl>-α-L-rhamnopyranioside 
• 141263-04-9 Benzyl 3-O-(4-O-acetyl-2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-2,4-di-O-benzyl-α-L-rhamnopyranoside 
• 141263-23-2 Benzyl 3-O-(4-O-acetyl-2,3,6-tri-O-benzyl-β-D-glucopyranosyl)-2,4-di-O-benzyl-α-L-rhamnopyranoside 
• 141263-10-7 1-O-Acetyl-2,4-di-O-benzyl-3-O-<2,3,6-tri-O-benzyl-4-O-(2,4,6-tri-O-acetyl-3-O-allyl-β-D-galactopyranosyl)-α-D-glucopyranosyl>-α-L-rhamnopyraniose 
• 141279-96-1 Methyl-2,4-di-O-benzyl-3-O-<2,3,6-tri-O-benzyl-4-O-(2,4,6-tri-O-acetyl-3-O-allyl-β-D-galactopyranosyl)-α-D-glucopyranosyl>-α-L-rhamnopyranioside 
• 141263-11-8 Methyl 2,4-di-O-benzyl-3-O-<2,3,6-tri-O-benzyl-4-O-(2,4,6-tri-O-acetyl-β-D-galactopyranosyl)-α-D-glucopyranosyl>-α-L-rhamnopyranoside 
• 141263-05-0 Benzyl 2,4-di-O-benzyl-3-O-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-α-L-rhamnopyranoside 
• 141263-03-8 ethyl 4-O-acetyl-2,3,6-tri-O-benzyl-1-thio-β-D-glucopyranoside 

Relevant articles and documents

Exploring glycosylation reactions under continuous-flow conditions

The industrial development of carbohydrate-based drugs is greatly thwarted by the typical challenges inherent in oligosaccharide synthesis. The practical advantages of continuous-flow synthesis in microreactors (high reproducibility, easy scalability, and fast reaction optimization) may offer an effective support to make carbohydrates more attractive targets for drug-discovery processes. Here we report a systematic exploration of the glycosylation reaction carried out under microfluidic conditions. Trichloroacetimidates and thioglycosides have been investigated as glycosyl donors, using both primary and secondary acceptors. Each microfluidic glycosylation has been compared with the corresponding batch reaction, in order to highlight advantages and drawbacks of microreactors technology. As a significant example of multistep continuous-flow synthesis, we also describe the preparation of a trisaccharide by means of two consecutive glycosylations performed in interconnected microreactors.

Synthesis of trisaccharide methyl glycosides related to fragments of the capsular polysaccharide of Streptococcus pneumoniae type 18C

The synthesis is reported of methyl 3-0-(4-0-β-D-galactopyranosyl-α-D-glucopyranosyl)-α-L- rhamnopyranoside (1), methyl 2-0-α-D-glucopyranosyl-4-0-β-D-glucopyranosyl-β-D- galactopyranoside (3), methyl 3-0-(4-0-β-D-galactopyranosyl-α-D-glucopyranosyl)-α-L-